Mostrando 2 resultados de: 2
Subtipo de publicación
Article(2)
Publisher
Journal of Clinical Oncology(2)
Área temáticas
Enfermedades(2)
Farmacología y terapéutica(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Medicina y salud(1)
Salud y seguridad personal(1)
Origen
scopus(2)
Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil Versus Fluorouracil, Epirubicin, and Cyclophosphamide Chemotherapy in Premenopausal Women with Axillary Node-Positive Operable Breast Cancer: Results of a Randomized Trial
ArticleAbstract: Purpose: To determine whether a combination chemotherapy regimen that contains epirubicin (fluorouraPalabras claves:Autores:Aapro M., Amadori D., Bliss J.M., Chilvers C.E.D., Coombes G., Coombes R.C., Espié M., Faustino R. Pérez-López, Gambrosier P., Marty M., McArdle C., Morvan F., Pinto Ferreira E., Richards M., Vassilopoulos P., Villar-Grimalt A., Wils J.A., Woods E.M.Fuentes:scopusEpirubicin plus tamoxifen versus tamoxifen alone in node-positive postmenopausal patients with breast cancer: A randomized trial of the International Collaborative Cancer Group
ArticleAbstract: Purpose: To assess whether the addition of epirubicin (EPI) therapy to prolonged treatment with tamoPalabras claves:Autores:Bliss J.M., Coombes G., Coombes R.C., Faustino R. Pérez-López, Fontaine C., Marty M., Morvan F., Olmos T., Vassilopoulos P., Wils J.A., Woods E.M.Fuentes:scopus